Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Articles published by Cure Rare Disease

Cure Rare Disease Receives FDA Feedback on Limb-Girdle 2i/R9 Gene Therapy Program Following Successful Pre-IND Meeting
From Cure Rare Disease
Via Business Wire
Cure Rare Disease Welcomes New Scientific and Strategic Leaders to Advance Therapies for Ultra-Rare Conditions
From Cure Rare Disease
Via Business Wire
Cure Rare Disease Receives Orphan Drug Designation from FDA for Investigational Therapy Targeting Spinocerebellar Ataxia Type 3 (SCA3)
From Cure Rare Disease
Via Business Wire
We Row For William: 157 Miles, One Nonstop Journey of Hope
From Cure Rare Disease
Via Business Wire
Cure Rare Disease Awarded $5.69 Million CIRM Grant to Advance Gene Therapy for Spinocerebellar Ataxia Type 3
From Cure Rare Disease
Via Business Wire
Cure Rare Disease Appoints Brittany Stineman as Chief Advancement Officer
From Cure Rare Disease
Via Business Wire
Cure Rare Disease Expands Leadership Team and Board of Directors to Advance Mission
From Cure Rare Disease
Via Business Wire
Cure Rare Disease Welcomes Leading Experts to Scientific Advisory Board
From Cure Rare Disease
Via Business Wire
Cure Rare Disease Receives Muscular Dystrophy Association Grant
From Cure Rare Disease
Via Business Wire
Cure Rare Disease Acquires Laboratory Space for New Headquarters in Connecticut
From Cure Rare Disease
Via Business Wire
Cure Rare Disease Receives FDA Approval to Administer First-in-Human CRISPR Therapeutic
From Cure Rare Disease
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.